denka

Denka Posts Increase to Chloroprene Rubber Sales as Part of Q1 Results

Denka Co. Ltd. (TYO:4061) has revealed its business results for the first quarter of fiscal 2021, marking a recovery from the same period last year. The company ended the quarter with a sales revenue of 86.73 billion yen ($789.69 million), up 13.8 percent year-on-year; operating profit of 7.75 billion yen, up 76 percent; ordinary profit of 7.52 billion yen, up...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading

Denka Takes Hit to Sales Results Despite Recovery for Chloroprene Rubber

Denka Co. Ltd. (TYO:4061) has released its business results for the first three quarters of fiscal 2020. The company revealed sales revenue of 261.99 billion yen ($2.51 billion) for the April–December period, down 9.2 percent year-on-year; an operating income of 28.03 billion yen, up 16.7 percent; an ordinary income of 27.3 billion yen, up 20.2 percent; and a net income...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading

Denka Releases Video Showcasing Company Efforts to Supply Ingredients for Antiviral Drug Avigan

Denka Co. Ltd. (TYO:4061) has released an approximately eight-minute video documenting its project to supply diethyl malonate for use in Avigan, an antiviral drug being touted as a potential treatment for COVID-19. The video has been made available on the company’s website. The video brings to life the story of how Denka, responding to a government request, managed to get...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading

Denka Posts 20% Year-on-Year Drop in Second-Quarter Sales

Denka Co. Ltd. (TYO:4061) posted 160.3 billion yen ($1.52 billion) in sales in its business report for the April–September quarter of fiscal 2020, marking a year-on-year  drop of 16.5 percent. Operating income was just under 12.07 billion yen, down 21.4 percent year on year, while ordinary income was 12.29 billion yen, down 15.4 percent, and net profit at 10 billion...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading

Denka Sees Revenue, Profits Drop for Q1 as CR Sales Take Hit From Coronavirus

Denka Co. Ltd. (TYO:4061) has shown a drop to both revenue and profits in its recently posted business results for the April–June quarter of fiscal 2020. The company revealed sales revenue of 76.23 billion yen ($719.68 million) for this first quarter, down by 16.1 percent year-on-year; operating income of 4.4 billion yen, down by 34.8 percent; ordinary income of 5.01...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading

Denka Pursues Domestic Approval for In Vitro Diagnostic Agent to be Used in COVID-19 Test Kits

Denka Co. Ltd. (TYO:4061) announced on July 20 that it has submitted an application to Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), looking here to get domestic regulatory approval for an in vitro diagnostic agent to be used in simple COVID-19 test kits. To help with developing the kit, Denka has pursued collaborative research with the National Institute of Infectious...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading